Food Science and Biotechnology

, Volume 19, Issue 6, pp 1673–1677 | Cite as

Cherry silver berry (Elaeagnus multiflora) extracts exert antiinflammatory effects by inhibiting COX-2 and Akt signals in HT-29 colon cancer cells

  • Mee Sook Lee
  • Yun-Kyoung Lee
  • Ock Jin ParkEmail author
Research Note


In this study, the potential of cherry silver berry (Elaeagnus multiflora) as a cancer preventive agent through regulating inflammatory signals including cyclooxygenase-2 (COX-2) and Akt was examined. Cherry silver berry has reported to exert anti-oxidative, anti-inflammatory, and anti-proliferative effects. The extracts from seed and flesh of cherry silver berry were obtained, and analyzed COX-2 and Akt activities in cherry silver berry extract treated HT-29 colon cancer cells. The results showed that the treatment of seed extracts reduced cell viability at the concentrations above 1,600 mg/mL, effectively reduced COX-2 and p-Akt expression. In addition, the anti-inflammatory effects seemed to be related to cancer cell death. Both of seed and flesh extracts inhibited cell growth and induced apoptosis in HT-29 cells. These results suggest that extracts of cherry silver berry may contribute to suppressing cancer growth through its anti-inflammatory and anti-proliferative effects, and natural products used as oriental medicine have the possibility to control tumor cell growth.


Akt cyclooxygenase-2 apoptosis colon cancer Elaeagnus multiflora 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M, Saremi S. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J. Ethnopharmacol. 72: 287–292 (2000)CrossRefGoogle Scholar
  2. 2.
    Lee YS, Chang ZQ, Oh BC, Park SC, Shin SR, Kim NW. Antioxidant activity, anti-inflammatory activity, and whitening effects of extracts of Elaeagnus multiflora Thunb. J. Med. Food 10: 126–133 (2007)CrossRefGoogle Scholar
  3. 3.
    Kim SA, Oh SI, Lee MS. Antioxidative and cytotoxic effects of solvent fractions from Elaeagnus multiflora. Korean J. Food Nutr. 2: 134–142 (2007)Google Scholar
  4. 4.
    Chang ZQ, Park SC, Oh BC, Lee YS, Shin SR, Kim NW. Antiplatelet aggregation and anti-inflammatory activity for extracts of Elaeagnus multiflora. Korean J. Med. Crop Sci. 14: 516–517 (2006)Google Scholar
  5. 5.
    Oh SI, Lee MS. Antioxidative and cytotoxic effects of ethanol extracts from Elaeagnus multiflora. Korean J. Food Nutr. 4: 403–409 (2008)Google Scholar
  6. 6.
    Breynaert C, Vermeire S, Rutgeerts P, Van Assche G. Dysplasia and colorectal cancer in inflammatory bowel disease: A result of inflammation or an intrinsic risk? Acta Gastro-Ent. Belg. 71: 367–372 (2008)Google Scholar
  7. 7.
    Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J. Gastroenterol. 14: 378–389 (2008)CrossRefGoogle Scholar
  8. 8.
    Sinicrope FA. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol. Carcinogen. 45: 447–454 (2006)CrossRefGoogle Scholar
  9. 9.
    Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. J. Cancer Metast. Rev. 23: 63–75 (2004)CrossRefGoogle Scholar
  10. 10.
    Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: A novel target for cancer chemotherapy? J. Cancer Res. Clin. 127: 411–417 (2001)CrossRefGoogle Scholar
  11. 11.
    Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol. Therapeut. 93: 243–251 (2002)CrossRefGoogle Scholar
  12. 12.
    Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. P. Natl. Acad. Sci. USA 98: 10983–10985 (2001)CrossRefGoogle Scholar
  13. 13.
    Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8: 627–644 (2009)CrossRefGoogle Scholar
  14. 14.
    Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Tar. 8: 187–198 (2008)CrossRefGoogle Scholar
  15. 15.
    Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277: 32124–32132 (2002)CrossRefGoogle Scholar
  16. 16.
    Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. New Engl. J. Med. 356: 2131–2142 (2007)CrossRefGoogle Scholar
  17. 17.
    Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 51: 511–523 (2000)CrossRefGoogle Scholar
  18. 18.
    Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230–232 (2003)CrossRefGoogle Scholar
  19. 19.
    Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Green tea polyphenols in the prevention of colon cancer. Front. Biosci. 12: 2309–2315 (2007)CrossRefGoogle Scholar
  20. 20.
    Fournier DB, Gordon GB. COX-2 and colon cancer: Potential targets for chemoprevention. J. Cell Biochem. S 34: 97–102 (2000)CrossRefGoogle Scholar
  21. 21.
    Reddy BS. Strategies for colon cancer prevention: Combination of chemopreventive agents. Sub-Cell. Biochem. 42: 213–225 (2007)CrossRefGoogle Scholar
  22. 22.
    Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI5K-Akt/PκB pathway. Anticancer Res. 26: 1177–1181 (2006)Google Scholar
  23. 23.
    Jiang H, Fan D, Zhou G, Li X, Deng H. Phosphatidylinositol3-kinase inhibitor (LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. J. Exp. Clin. Canc. Res. 29: 34–40 (2010)CrossRefGoogle Scholar

Copyright information

© The Korean Society of Food Science and Technology and Springer Netherlands 2010

Authors and Affiliations

  1. 1.Department of Food and NutritionHannam University Daedeok Valley CampusDaejeonKorea

Personalised recommendations